Development and Testing of a Smartphone-Based Cognitive/Neuropsychological Evaluation System for Substance Abusers

References

• Antony, M. M., P. J. Bieling, B. J. Cox, M. W. Enns, and R. P. Swinson. 1998. Psychometric properties of the 42-item and 21-item versions of the Depression Anxiety Stress Scales (DASS) in clinical groups and a community sample. Psychological Assessment 10 (2):176–81. doi:10.1037/1040-3590.10.2.176.
   Web of Science ®Google Scholar
• Bolger, N., and E. A. Schilling. 1991. Personality and the problems of everyday life: The role of neuroticism in exposure and reactivity to daily stressors. Journal of Personality 59 (3):355–86. doi:10.1111/j.1467-6494.1991.tb00253.x.
   PubMed Web of Science ®Google Scholar
• Camacho, L. M., B. S. Brown, and D. D. Simpson. 1996. Psychological dysfunction and HIV/AIDS risk behavior. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology 11 (2):198–202. doi:10.1097/00042560-199602010-00012.
   PubMedGoogle Scholar
• Galloway, G. P., E. G. Singleton, and The Methamphetamine Treatment Project Corporate. 2009. How long does craving predict use of methamphetamine? Assessment of use one to seven weeks after the assessment of craving: Craving and ongoing methamphetamine use. Substance Abuse: Research and Treatment 1:63–79.
   PubMedGoogle Scholar
• Galloway, G. P., E. G. Singleton, R. Buscemi, M. J. Baggott, R. M. Dickerhoof, J. E. Mendelson, and Methamphetamine Treatment Project Corporate. 2010. An examination of drug craving over time in abstinent methamphetamine users. The American Journal on Addictions 19 (6):510–14. doi:10.1111/j.1521-0391.2010.00082.x.
   PubMed Web of Science ®Google Scholar
• Hartz, D. T., S. L. Frederick-Osborne, and G. P. Galloway. 2001. Craving predicts use during treatment for methamphetamine dependence: A prospective, repeated-measures, within-subject analysis. Drug and Alcohol Dependence 63 (3):269–76. doi:10.1016/S0376-8716(00)00217-9.
   PubMed Web of Science ®Google Scholar
• James, D., G. Davies, and P. Willner. 2004. The development and initial validation of a questionnaire to measure craving for amphetamine. Addiction 99 (9):1181–88. doi:10.1111/add.2004.99.issue-9.
   PubMed Web of Science ®Google Scholar
• Lovibond, P. F., and S. H. Lovibond. 1995a. The structure of negative emotional states: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck depression and anxiety inventories. Behaviour Research and Therapy 33 (3):335–43. doi:10.1016/0005-7967(94)00075-U.
   PubMed Web of Science ®Google Scholar
• Lovibond, S. H., and P. F. Lovibond. 1995b. Manual for the depression anxiety stress scales, 2nd ed. Sydney, Australia: Psychology Foundation.
   Google Scholar
• MacLeod, C. M. 2005. The Stroop task in cognitive research. In Cognitive methods and their application to clinical research, eds. A. Wenzel and D. Rubin. Vienna, Austria: American Psychological Association.
   Google Scholar
• McGregor, C., M. Srisurapanont, J. Jittiwutikarn, S. Laobhripatr, T. Wongtan, and J. M. White. 2005. The nature, time course and severity of methamphetamine withdrawal. Addiction 100 (9):1320–29. doi:10.1111/j.1360-0443.2005.01160.x.
   PubMed Web of Science ®Google Scholar
• Monterosso, J. R., A. R. Aron, X. Cordova, J. Xu, and E. D. London. 2005. Deficits in response inhibition associated with chronic methamphetamine abuse. Drug and Alcohol Dependence 79 (2):273–77. doi:10.1016/j.drugalcdep.2005.02.002.
   PubMed Web of Science ®Google Scholar
• Salo, R., T. E. Nordahl, M. H. Buonocore, Y. Natsuaki, C. Waters, C. D. Moore, G. P. Galloway, and M. H. Leamon. 2009a. Cognitive control and white matter callosal microstructure in methamphetamine-dependent subjects: A diffusion tensor imaging study. Biological Psychiatry 65 (2):122–28. doi:10.1016/j.biopsych.2008.08.004.
   PubMed Web of Science ®Google Scholar
• Salo, R., T. E. Nordahl, G. P. Galloway, C. D. Moore, C. Waters, and M. H. Leamon. 2009b. Drug abstinence and cognitive control in methamphetamine-dependent individuals. Journal of Substance Abuse Treatment 37 (3):292–97. doi:10.1016/j.jsat.2009.03.004.
   PubMed Web of Science ®Google Scholar
• Salo, R., T. E. Nordahl, Y. Natsuaki, M. H. Leamon, G. P. Galloway, C. Waters, C. D. Moore, and M. H. Buonocore. 2007. Attentional control and brain metabolite levels in methamphetamine abusers. Biological Psychiatry 61 (11):1272–80. doi:10.1016/j.biopsych.2006.07.031.
   PubMed Web of Science ®Google Scholar
• Salo, R., T. E. Nordahl, K. Possin, M. Leamon, D. R. Gibson, G. P. Galloway, N. M. Flynn, A. Henik, A. Pfefferbaum, and E. V. Sullivan. 2002. Preliminary evidence of reduced cognitive inhibition in methamphetamine-dependent individuals. Psychiatry Research 111 (1):65–74. doi:10.1016/S0165-1781(02)00111-7.
   PubMed Web of Science ®Google Scholar
• Salo, R., S. Ursu, M. H. Buonocore, M. H. Leamon, and C. Carter. 2009c. Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: A functional magnetic resonance imaging study. Biological Psychiatry 65 (8):706–09. doi:10.1016/j.biopsych.2008.11.026.
   PubMed Web of Science ®Google Scholar
• Scott, J. C., S. P. Woods, G. E. Matt, R. A. Meyer, R. K. Heaton, J. H. Atkinson, and I. Grant. 2007. Neurocognitive effects of methamphetamine: A critical review and meta-analysis. Neuropsychology Review 17 (3):275–97. doi:10.1007/s11065-007-9031-0.
   PubMed Web of Science ®Google Scholar
• Silverstein, S. M., S. Berten, P. Olson, R. Paul, L. M. Willams, N. Cooper, and E. Gordon. 2007. Development and validation of a world-wide-web-based neurocognitive assessment battery: WebNeuro. Behavior Research Methods 39 (4):940–49. doi:10.3758/BF03192989.
   PubMed Web of Science ®Google Scholar
• Sinha, R. 2011. New findings on biological factors predicting addiction relapse vulnerability. Current Psychiatry Reports 13 (5):398–405. doi:10.1007/s11920-011-0224-0.
   PubMed Web of Science ®Google Scholar
• Srisurapanont, M., N. Jarusuraisin, and J. Jittiwutikan. 1999. Amphetamine withdrawal: I. Reliability, validity and factor structure of a measure. The Australian and New Zealand Journal of Psychiatry 33 (1):89–93. doi:10.1046/j.1440-1614.1999.00517.x.
   PubMed Web of Science ®Google Scholar
• Tiffany, S. T., and J. M. Wray. 2012. The clinical significance of drug craving. Annals of the New York Academy of Sciences 1248:1–17. doi:10.1111/j.1749-6632.2011.06298.x.
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime (UNODC). 2014. World drug report. Washington, DC: United Nations.
   Google Scholar
• Verbruggen, F., and G. D. Logan. 2008. Response inhibition in the stop-signal paradigm. Trends in Cognitive Sciences 12 (11):418–24. doi:10.1016/j.tics.2008.07.005.
   PubMed Web of Science ®Google Scholar
• Verbruggen, F., G. D. Logan, and M. A. Stevens. 2008. STOP-IT: Windows executable software for the stop-signal paradigm. Behavior Research Methods 40 (2):479–83. doi:10.3758/BRM.40.2.479.
   PubMed Web of Science ®Google Scholar